These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 223981)

  • 21. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.
    Ridgely SL; McGuire TC
    Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equine infectious anemia virus from infected horse serum.
    Nakajima H; Yoshino T; Ushimi C
    Infect Immun; 1974 Sep; 10(3):667-8. PubMed ID: 4372175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phagocytosis of horse erythrocytes treated with equine infectious anemia virus by cultivated horse leukocytes.
    Sentsui H; Kono Y
    Arch Virol; 1987; 95(1-2):67-77. PubMed ID: 3036046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection.
    Evans KS; Carpenter SL; Sevoian M
    Am J Vet Res; 1984 Jan; 45(1):20-5. PubMed ID: 6322623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
    Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
    Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.
    Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC
    J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of precipitating antibody in equine infectious anemia.
    Nakajima H; Kono Y; Ushimi C
    J Immunol; 1971 Sep; 107(3):889-94. PubMed ID: 4328472
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitation of immunoglobulin-bearing lymphocytes and lymphocyte response to mitogens in horses persistently infected by equine infectious anemia virus.
    Banks KL; Henson JB
    Infect Immun; 1973 Oct; 8(4):679-82. PubMed ID: 4582640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
    DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).
    Newman MJ; Issel CJ; Truax RE; Powell MD; Horohov DW; Montelaro RC
    Virology; 1991 Sep; 184(1):55-66. PubMed ID: 1651604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs.
    Kono Y; Hirasawa K; Fukunaga Y; Taniguchi T
    Natl Inst Anim Health Q (Tokyo); 1976; 16(1):8-15. PubMed ID: 177894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the host immune response in selection of equine infectious anemia virus variants.
    Carpenter S; Evans LH; Sevoian M; Chesebro B
    J Virol; 1987 Dec; 61(12):3783-9. PubMed ID: 2446008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health and epidemiological approaches of Trypanosoma evansi and equine infectious anemia virus in naturally infected horses at southern Pantanal.
    Parreira DR; Jansen AM; Abreu UG; Macedo GC; Silva AR; Mazur C; Andrade GB; Herrera HM
    Acta Trop; 2016 Nov; 163():98-102. PubMed ID: 27497875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of precipitating antibody in equine infectious anemia by concentrated virus antigen.
    Nakajima H; Ushimi C
    Natl Inst Anim Health Q (Tokyo); 1972; 12(2):47-53. PubMed ID: 4340682
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.
    Lonning SM; Zhang W; Leib SR; McGuire TC
    J Virol; 1999 Apr; 73(4):2762-9. PubMed ID: 10074123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural proteins of equine infectious anemia virus and their antigenic activity.
    Nishimura M; Nakajima H
    Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
    Sentsui H; Kono Y
    Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological comparison among various strains of equine infectious anemia virus.
    Kono Y; Kobayashi K; Fukunaga Y
    Arch Gesamte Virusforsch; 1971; 34(3):202-8. PubMed ID: 4330134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.